These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 20926112

  • 1. Influence of an additional amino group on the potency of aminoadamantanes against influenza virus A. II - Synthesis of spiropiperazines and in vitro activity against influenza A H3N2 virus.
    Fytas C, Kolocouris A, Fytas G, Zoidis G, Valmas C, Basler CF.
    Bioorg Chem; 2010 Dec; 38(6):247-51. PubMed ID: 20926112
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
    Zoidis G, Kolocouris N, Naesens L, De Clercq E.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1534-41. PubMed ID: 19195900
    [Abstract] [Full Text] [Related]

  • 3. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Göktaş F, Vanderlinden E, Naesens L, Cesur N, Cesur Z.
    Bioorg Med Chem; 2012 Dec 15; 20(24):7155-9. PubMed ID: 23117173
    [Abstract] [Full Text] [Related]

  • 4. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y, Musharrafieh R, Ma C, Zhang J, Smee DF, DeGrado WF, Wang J.
    Antiviral Res; 2017 Apr 15; 140():45-54. PubMed ID: 28087313
    [Abstract] [Full Text] [Related]

  • 5. Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues.
    Kolocouris A, Spearpoint P, Martin SR, Hay AJ, López-Querol M, Sureda FX, Padalko E, Neyts J, De Clercq E.
    Bioorg Med Chem Lett; 2008 Dec 01; 18(23):6156-60. PubMed ID: 18947998
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and antiviral activity evaluation of some aminoadamantane derivatives.
    Kolocouris N, Foscolos GB, Kolocouris A, Marakos P, Pouli N, Fytas G, Ikeda S, De Clercq E.
    J Med Chem; 1994 Sep 02; 37(18):2896-902. PubMed ID: 8071937
    [Abstract] [Full Text] [Related]

  • 7. Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A.
    Tataridis D, Fytas G, Kolocouris A, Fytas C, Kolocouris N, Foscolos GB, Padalko E, Neyts J, De Clercq E.
    Bioorg Med Chem Lett; 2007 Feb 01; 17(3):692-6. PubMed ID: 17113287
    [Abstract] [Full Text] [Related]

  • 8. New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine.
    Shibnev VA, Garaev TM, Finogenova MP, Shevchenko ES, Burtseva EI.
    Bull Exp Biol Med; 2012 Jun 01; 153(2):233-5. PubMed ID: 22816091
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.
    Kolocouris N, Kolocouris A, Foscolos GB, Fytas G, Neyts J, Padalko E, Balzarini J, Snoeck R, Andrei G, De Clercq E.
    J Med Chem; 1996 Aug 16; 39(17):3307-18. PubMed ID: 8765514
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors.
    Göktaş F, Özbil M, Cesur N, Vanderlinden E, Naesens L, Cesur Z.
    Arch Pharm (Weinheim); 2019 Nov 16; 352(11):e1900028. PubMed ID: 31531897
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H, Wan J, Lin MI, Liu Y, Lu X, Liu J, Xu Y, Chen J, Tu Z, Cheng YS, Ding K.
    J Med Chem; 2012 Mar 08; 55(5):2144-53. PubMed ID: 22332894
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
    Yu M, Liu A, Du G, Naesens L, Vanderlinden E, De Clercq E, Liu X.
    Chem Biol Drug Des; 2011 Oct 08; 78(4):596-602. PubMed ID: 21752202
    [Abstract] [Full Text] [Related]

  • 18. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains.
    Kuznetsov NY, Tikhov RM, Godovikov IA, Medvedev MG, Lyssenko KA, Burtseva EI, Kirillova ES, Bubnov YN.
    Org Biomol Chem; 2017 Apr 11; 15(15):3152-3157. PubMed ID: 28338150
    [Abstract] [Full Text] [Related]

  • 19. Adamantylthiourea derivatives as antiviral agents.
    Tilley JW, Levitan P, Kramer MJ.
    J Med Chem; 1979 Aug 11; 22(8):1009-10. PubMed ID: 490532
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.